The role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcers

Gastroenterology Clinics of North America

Volumn 32, Issue 3 SUPPL., 2003, Pages

  Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

BLOOD TRANSFUSION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; DOSE RESPONSE; GASTRODUODENAL ULCER; GASTROSCOPY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; META ANALYSIS; MORBIDITY; MORTALITY; PEPTIC ULCER BLEEDING; STOMACH ACID SECRETION; STOMACH PH; STOMACH SURGERY; STRESS ULCER; TABLET FORMULATION; TACHYPHYLAXIS; THERMOCOAGULATION; ULCER HEALING;

EID: 0141483282     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00058-X     Document Type: Conference Paper

References (34)

1. Mondardini A, Barletti C, Rocca G, et al. Nonvariceal upper gastrointestinal bleeding and Forrest's classification: diagnostic agreement between endoscopists from the same area. Endoscopy 1998;30:508-12.
2. Allan R, Dykes P. A study of the factors influencing mortality rates from gastrointestinal haemorrhage. Quarterly Journal of Medicine 1976;45:533-50.
3. Silverstein FE, Gilbert DA, Tedesco FJ, et al, and 277 members of the ASGE. The national ASGE survey on upper gastrointestinal bleeding, II. Clinical prognostic factors. Gastrointest Endosc 1981;27:80-93.
4. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-21.
5. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest Endosc 1990;36:S8-13.
6. Chung SS, Lau JY, Sung JJ, et al. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 1997;314:1307-11.
7. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27.
8. Saeed ZA, Winchester CB, Michaletz PA, et al. A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection. Am J Gastroenterol 1993;88:1842-9.
9. Rockall TA, Logan RF, Devlin HB, et al. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet 1996;347:1138-40.
10. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.
11. Bustamante M, Stollman N. The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review. J Clin Gastroenterol 2000;30:7-13.
12. Chung SC, Leung JW, Sung JY, et al. Injection or heat probe for bleeding ulcer. Gastroenterology 1991;100:33-7.
13. Kubba AK, Murphy W, Palmer KR. Endoscopic injection for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus human thrombin. Gastroenterology 1996;111:623-8.
14. Johnston JH, Jensen DM, Auth D. Experimental comparison of endoscopic yttrium-aluminum-garnet laser, electrosurgery, and heater probe for canine gut arterial coagulation. Importance of compression and avoidance of erosion. Gastroenterology 1987;92:1101-8.
15. Green FWJ, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.
16. 2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985;313:660-6.
17. Walt RP, Cottrell J, Mann SG, et al. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992;340:1058-62.
18. Daneshmend TK, Hawkey CJ, Langman MJ, et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double-blind controlled trial. BMJ 1992;304:143-7.
19. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997;336:1054-8.
20. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997;32:328-33.
21. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994;106:60-4.
22. Netzer P, Gaia C, Sandoz M, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999;94:351-7.
23. Pisegna JR, Martin P, McKeand W, et al. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study. Am J Gastroenterol 1999;94:2874-80.
24. Rioux KP. Is administration of intravenous proton pump inhibitor to all patients presenting with upper gastrointestinal bleeding cost savings? [abstract] Gastrointest Endosc 2001;53:A478.
25. Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs 1997;54:581-96.
26. Spirt M, Guth PH, Leung FW, et al. Critically ill septic ICU patients have severe upper gastrointestinal mucosal ischemia [abstract]. Gastroenterology 1995;108:A326.
27. Konturek SJ. Prostaglandins in pathophysiology of peptic ulcer disease. Dig Dis Sci 1985;30:105S-8S.
28. Malledant Y, Tanguy M, Saint-Marc C. Digestive stress hemorrhage. Physiopathology and prevention [in French]. Ann Fr Anesth Reanim 1989;8:334-46.
29. Lam NP, Le PD, Crawford SY, et al. National survey of stress ulcer prophylaxis. Crit Care Med 1999;27:98-103.
30. Sharma VK. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole. Am J Health Syst Pharm 1999;56:S18-21.
31. Paul J, Ferron GM, Ku S, et al. Pantoprazole bicarbonate suspension (PBS) provides oral bioavailability comparable to tablet [563/T151] [abstract]. Crit Care Med 2000;28:A184.
32. Phillips JO, Metzler MH, Palmieri TL, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996;24:1793-800.
33. Levy MJ, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997;42:1255-9.
34. Somberg L, Karlstadt R, Gallagher K, et al. Intravenous pantoprazole rapidly achieves pH > 4.0 in ICU patients without the development of tolerance [abstract]. Gastroenterology 2001;120:A157-8.